Home › Pagkabigo ng Puso › Vermont
Pag-aaral pangklinika para sa Pagkabigo ng Puso sa Vermont
8 pag-aaral para sa Pagkabigo ng Puso ang naghahanap ng mga kalahok sa mga site sa Vermont.
Mga Lungsod sa Vermont
Opisyal na teksto ng pag-aaral (English)
ELEVATE-HFpEF Clinical Study
- The University of Vermont Medical Center, Burlington
Nagre-recruit
Edad 40 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT06678841Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
- Research Site, Burlington
Nagre-recruitPhase 3
Edad 40 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT06677060A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
- Burlington, VT Investigative Site 10053, Burlington
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 10, 2026 · NCT06008197Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
- Burlington
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Ago 20, 2026 · NCT00271180A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists
- FIN-10053, Burlington, VT, Burlington
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 10, 2026 · NCT06033950PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
- University of Vermont, Burlington
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT05934487His-Bundle Corrective Pacing in Heart Failure
- University of Vermont, Burlington
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Peb 9, 2026 · NCT05265520Left vs Left Randomized Clinical Trial
- University of Vermont, Burlington
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2025 · NCT05650658Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.